GERMANY APPROVES 1st CLINICAL TRIAL OF COVID-19
Photo: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus Covid-19" words in this illustration taken April 10, 2020. (Reuters Archive)
Germany approves first clinical trial of Covid-19 vaccine
Germany's vaccines regulator approved live human testing of a potential vaccine against the Covid-19 virus developed by German biotech company BioNTech, the regulator said in a statement.
The trial, only the fourth worldwide of a preventive agent targeting the virus behind the global pandemic, will be conducted on 200 healthy people aged between 18 and 55 in the first stage, and on further people, including those at higher risk from the disease, in a second stage.
BioNTech said it was developing the vaccine candidate, named BNT162, together with its partner, pharma giant Pfizer.
Tests of the vaccine were also planned in the US, once regulatory approval for testing on humans had been secured there. via Reuters
Photo: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus Covid-19" words in this illustration taken April 10, 2020. (Reuters Archive)
Germany approves first clinical trial of Covid-19 vaccine
Germany's vaccines regulator approved live human testing of a potential vaccine against the Covid-19 virus developed by German biotech company BioNTech, the regulator said in a statement.
The trial, only the fourth worldwide of a preventive agent targeting the virus behind the global pandemic, will be conducted on 200 healthy people aged between 18 and 55 in the first stage, and on further people, including those at higher risk from the disease, in a second stage.
BioNTech said it was developing the vaccine candidate, named BNT162, together with its partner, pharma giant Pfizer.
Tests of the vaccine were also planned in the US, once regulatory approval for testing on humans had been secured there. via Reuters
Comments
Post a Comment